ARCHIVES

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

PDF file includes 8-page February issue of Business & Regulatory Report.

February 27, 2004

Group Chairs Seek Role Running NCTN

September 12, 2014

Cancer Centers: John Glick to step down after 21 years directing Penn’s Abramson Cancer Center.

December 2, 2005

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985